Efficacy of Early Pegylated Interferon α-2b Monotherapy for Acute Hepatitis C in HIV-Infected Patients

被引:3
|
作者
De Rosa, Francesco G. [1 ]
Mollaretti, Oscar [1 ]
Audagnotto, Sabrina [1 ]
De Blasi, Tiziano [1 ]
Cariti, Giuseppe [1 ]
Marucco, Diego M. Aguilar [1 ]
Bonora, Stefano [1 ]
Di Perri, Giovanni [1 ]
机构
[1] Osped Amedeo di Savoia, Dept Infect Dis, Turin, Italy
关键词
VIRUS;
D O I
10.1086/598995
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1636 / 1637
页数:2
相关论文
共 50 条
  • [1] Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients
    Dominguez, Stephanie
    Ghosn, Jade
    Valantin, Marc-Antoine
    Schruniger, Aurelie
    Simon, Anne
    Bonnard, Philippe
    Caumes, Eric
    Pialoux, Gilles
    Benhamou, Yves
    Thibault, Vincent
    Katlama, Christine
    AIDS, 2006, 20 (08) : 1157 - 1161
  • [2] Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Moreno, L
    Quereda, C
    Moreno, A
    Perez-Elías, MJ
    Antela, A
    Casado, JL
    Dronda, F
    Mateos, ML
    Bárcena, R
    Moreno, S
    AIDS, 2004, 18 (01) : 67 - 73
  • [3] Efficacy and safety of pegylated interferon-α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Santin, M
    Shaw, E
    Garcia, MJ
    Delejido, A
    De Castro, ER
    Rota, R
    Altés, J
    Baguena, F
    Valero, S
    Sala, M
    Casanova, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (04) : 315 - 320
  • [4] Pegylated interferon-α monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C
    Arends, Joop E.
    van Assen, Sander
    Stek, Carl J.
    Wensing, Annemarie M. J.
    Fransen, Justin H.
    Schellens, Ingrid M.
    Spijkers, Sanne N. M.
    Mudrikova, Tania
    van Baarle, Debbie
    Sprenger, Herman G.
    Hoepelman, Andy I. M.
    ANTIVIRAL THERAPY, 2011, 16 (07) : 979 - 988
  • [5] Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Berenguer, J.
    Gonzalez-Garcia, J.
    Lopez-Aldeguer, J.
    Von-Wichmann, M. A.
    Quereda, C.
    Hernando, A.
    Sanz, J.
    Tural, C.
    Ortega, E.
    Mallolas, J.
    Santos, I.
    Miralles, P.
    Montes, M. L.
    Bellon, J. M.
    Esteban, H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1256 - 1263
  • [6] Treatment of chronic hepatitis C in HIV-infected patients with interferon α-2b plus ribavirin
    Pérez-Olmeda, M
    Soriano, V
    Asensi, V
    Morales, D
    Romero, M
    Ochoa, A
    Sánchez-Montero, F
    Santin, M
    Guardiola, J
    Blanch, J
    Núñez, M
    Jiménez-Nácher, I
    García-Samaniego, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (12) : 1083 - 1089
  • [7] Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients
    Landau, A
    Batisse, D
    Van Huyen, JPD
    Piketty, C
    Bloch, F
    Pialoux, G
    Belec, L
    Petite, JP
    Weiss, L
    Kazatchkine, M
    AIDS, 2000, 14 (07) : 839 - 844
  • [8] Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon α2a or α2b
    Vispo, Eugenia
    Barreiro, Pablo
    Rodriguez-Novoa, Sonia
    Morello, Judit
    Lobarga, Pablo
    Martin-Carbonero, Luz
    Maida, Ivana
    Garcia-Gasco, Pilor
    Soriano, Vincent
    ANTIVIRAL THERAPY, 2008, 13 (04) : 511 - 517
  • [9] Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C
    Annicchiarico, BE
    Siciliano, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (01) : 123 - 124
  • [10] Randomized trial of pegylated interferon α-2b monotherapy in haemodialysis patients with chronic hepatitis C
    Russo, MW
    Ghalib, R
    Sigal, S
    Joshi, V
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (02) : 437 - 443